legal-news

1:21-cv-01229 UCB, Inc. et al v. Cipla Limited et al

updateUpdated 1 day ago
21-cv-01229 Filed
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

UCB, Inc. et al v. Cipla Limited et al involves a dispute between pharmaceutical companies, likely concerning patent or intellectual property rights given the parties involved. The docket references a redacted document, indicating sensitive information is part of the case record.

Stage

Active litigation

Timeline

2 events

Coverage

2 articles

Sources

1

Key Issues

  • Patent infringement
  • Pharmaceutical intellectual property
  • Confidentiality and redactions

update What Changed This Week

2 events 2 articles
Advertisement

Case Timeline

2 events
info
Other April 15, 2026

2:21-cv-01229 Suzuki et al v. Marinepolis USA Inc et al

In the case Suzuki et al v. Marinepolis USA Inc et al, the United States Court of Appeals issued a mandate, which is an official order that typically concludes the appellate court's involvement and directs the lower court on how to proceed. This step is important because it signals the final decision or instructions from the appellate court, impacting the next phase of the case.

info
Other April 15, 2026

1:21-cv-01229 UCB, Inc. et al v. Cipla Limited et al

In the case between UCB, Inc. and Cipla Limited, a document was filed under seal, meaning its contents are hidden from the public record. This often happens to protect sensitive information such as trade secrets or confidential business details. The filing ensures that important private information remains secure while the case proceeds.

Advertisement
show_chart

Coverage Timeline

newspaper

Press Coverage

2 articles